医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Targeting Apoptosis Pathways With BCL2 and MDM2 Inhibitors in Adult B-cell Acute Lymphoblastic Leukemia.

广告
第一作者: Helena,Hohtari
第一单位: Translational Immunology Research Program, University of Helsinki, Finland.;Hematology Research Unit Helsinki, University of Helsinki, and Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
作者单位: Translational Immunology Research Program, University of Helsinki, Finland.;Hematology Research Unit Helsinki, University of Helsinki, and Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland. [1] Translational Immunology Research Program, University of Helsinki, Finland.;Hematology Research Unit Helsinki, University of Helsinki, and Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.;Laboratory of Genetics, HUS Diagnostic Center, Hospital District of Helsinki and Uusimaa (HUS), Helsinki, Finland.;Medical and Clinical Genetics, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.;iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland. [2] Translational Immunology Research Program, University of Helsinki, Finland.;Hematology Research Unit Helsinki, University of Helsinki, and Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.;Clinical and Chemical Pathology Department, National Cancer Institute, Cairo University, Giza, Egypt. [3] Institute for Molecular Medicine Finland, University of Helsinki, Finland. [4] Translational Immunology Research Program, University of Helsinki, Finland.;Hematology Research Unit Helsinki, University of Helsinki, and Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.;iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland. [5] iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.;Institute for Molecular Medicine Finland, University of Helsinki, Finland. [6] Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Austria. [7] Laboratory of Genetics, HUS Diagnostic Center, Hospital District of Helsinki and Uusimaa (HUS), Helsinki, Finland.;Medical and Clinical Genetics, University of Helsinki, Helsinki University Hospital, Helsinki, Finland. [8] Translational Immunology Research Program, University of Helsinki, Finland.;Hematology Research Unit Helsinki, University of Helsinki, and Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.;iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.;Department of Clinical Chemistry, University of Helsinki, Finland. [9]
DOI 10.1097/HS9.0000000000000701
PMID 35233509
发布时间 2022-03-09
提交
  • 浏览0
HemaSphere

HemaSphere

2022年6卷3期

e701页

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷